Login or sign up
For business

Iomai Corporation

3.9ยท 10 reviews
Average ratingAverage
3.9/ 5

Based on 10 reviews

530%
430%
340%
20%
10%
Ask AI

What reviewers say about Iomai Corporation

Based on 10 reviews, listing data and website checks ยท updated yesterday

Customers consistently describe Iomai Corporation as an excellent or outstanding company with high-quality products and services, professional and dedicated teams, and outstanding customer service. Several reviewers also recommend the company, while one specifically praised its company culture, management support, growth opportunities, and work-life balance.
What is Iomai Corporation?

Iomai Corporation develops vaccines and immune system stimulants using transcutaneous immunization (TCI), a needle-free technology that targets antigen-presenting cells in the skin to enhance immune responses. The company was incorporated in 1997 and is based in Gaithersburg, Maryland. It aims to improve existing vaccines, create new ones viable only through TCI, and expand the global vaccine market.

Where is Iomai Corporation located and what markets does it serve?

The business is located in Gaithersburg, Maryland, and operates in the United States. Its needle-free TCI technology accesses the outer layers of the skin to generate an enhanced immune response, which is a key feature of their vaccine delivery system.

How long has Iomai Corporation existed and what is its history?

Iomai Corporation was incorporated in 1997 and has been operating for over two decades. The company was formerly known as Intercell USA, Inc. before the acquisition of Iomai Corporation.

What specific technology does Iomai Corporation use for its vaccines?

According to the company's own website, TCI taps into the unique benefits of antigen-presenting cells found in the outer layers of the skin. This technology allows for the generation of an enhanced immune response, which is central to their vaccine development strategy.

What are Iomai Corporation's main goals and product focuses?

The company's goal is to enhance the efficacy of existing vaccines, enable new vaccines that are viable only through transcutaneous administration, and expand the global vaccine market. These objectives define their core mission and product focus.

What do reviewers praise about Iomai Corporation?

Some reviewers on Trustburn praise Iomai Corporation for their dedication to providing exceptional products and services. Customers also highlight the team's ability to go above and beyond to ensure customer satisfaction.

What common themes appear in the customer reviews?

Some reviewers mention that Iomai Corporation's products are fantastic and their customer service is outstanding. Others note that the company culture is great and the management team is very supportive.

What unique feature does Iomai Corporation offer in its vaccine delivery?

The company's website mentions that TCI is a novel, needle-free technology. This feature distinguishes their approach to vaccine delivery from traditional methods.

What is the official website of Iomai Corporation?

The official website of Iomai Corporation is iomai.com.

How is Iomai Corporation rated on Trustburn?

On Trustburn, Iomai Corporation has a rating of 3.9 out of 5 based on 10 reviews.

AI-generated from reviews on this page. Verify anything important with the company directly.

Jim Perna
Reviews 1

Iomai Corporation is an excellent company to work for. The company culture is great, and the management team is very supportive. There are many opportunities for growth and development, and the work-life balance is fantastic. I am proud to be a part of the Iomai family.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website โ€” a simple way to convert your visitors into customers.

Get the widget for your site →

About Iomai Corporation

Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology called transcutaneous immunization (TCI). TCI taps into the unique benefits of a major group of antigen-presenting cells found in the outer layers of the skin to generate an enhanced immune response.

Iomai is leveraging TCI to enhance the efficacy of existing vaccines, enable new vaccines that are viable only through transcutaneous administration and expand the global vaccine market.

The company was incorporated in 1997 and is based in Gaithersburg, Maryland. Intercell USA, Inc. was formerly known as Iomai Corporation. As a result of the acquisition of Iomai Corporation by Intercell Ag, Iomai Corporation's name was changed. As of August 5, 2008, Intercell USA, Inc. operates as a subsidiary of Intercell Biomedical Research & Development AG.

Website
iomai.com